Homozygosity at the C677T of the MTHFR gene is associated with increased breast cancer risk in the Turkish population

In Vivo

Volumn 19, Issue 5, 2005, Pages 889-894

  Deligezer, Ugur ^a   Akisik, E Ebru ^a   Dalay, Nejat ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Breast cancer susceptibility; Melting curve analysis; MTHFR; Polymorphism

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ALANINE; CYTOSINE; FOLIC ACID; THYMINE; VALINE;

ADULT; AGED; ALLELE; ARTICLE; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; FEMALE; FOLIC ACID DEFICIENCY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MODULATION; ONSET AGE; SINGLE NUCLEOTIDE POLYMORPHISM; TURKEY (REPUBLIC);

EID: 23044484714     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. McPherson K, Steel CM and Dixon JM: Breast cancer-epidemiology, risk factors, and genetics. BMJ 321: 624-628, 2000.
2. Duthie SJ: Folic acid deficiency and cancer: mechanisms of DNA instability. Br Med Bull 55: 578-592, 1999.
3. Eichholzer M, Luthy J, Moser U and Fowler B: Folate and the risk of colorectal, breast and cervix cancer: the epidemiological evidence. Swiss Med Wkly 131: 539-549, 2001.
4. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP et al: Candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature Genet 10: 111-113, 1995.
5. Van der Put NM, Gabreels F, Stevens EM, Smeitink JA, Trijbels FJ, Eskes TK, van den Heuvel LP and Blom HJ: A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet 62: 1044-1051, 1998.
6. Keku T, Millikan R, Worley K, Winkel S, Eaton A, Biscocho L, Martin C and Sandler R: 5,10-Methylenetetrahydrofolate reductase codon 677 and 1298 polymorphisms and colon cancer in African Americans and whites. Cancer Epidemiol Biomarkers Prev 11: 1611-1621, 2002.
7. Zhang J, Zotz RB, Li Y, Wang R, Kiel S, Schulz WA, Wen D, Chen Z, Zhang L, Wang S, Gabbert HE and Sarbia M: Methylenetetrahydrofolate reductase C677T polymorphism and predisposition towards esophageal squamous cell carcinoma in a German Caucasian and a northern Chinese population. J Cancer Res Clin Oncol 130: 574-580, 2004.
8. Chen J, Giovannucci E, Kelsey K Rimm EB, Stampfer MJ, Colditz GA, Spiegelman D, Willett WC and Hunter DJ: A methylenetetrahydrofolate reductase polymophism and the risk of colorectal cancer. Cancer Res 56: 4862-4864, 1996.
9. Esteller M, Garcia A, Martinez-Palones JM, Xercavins J and Reventos J: Germ line polymorphisms in cytochrome-P450 1A1 (C4887 CYP1A1) and methylenetetrahydrofolate reductase (MTHFR) genes and endometrial cancer susceptibility. Carcinogenesis 18: 2307-2311, 1997.
10. Skibola CF, Smith MT, Kane E, Roman E, Rollinson S, Cartwright RA and Morgan G: Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults. Proc Natl Acad Sci USA 96: 12810-12815, 1999.
11. Piyathilake CJ, Macaluso M, Johanning, GL, Whiteside M, Heimburger DC and Giuliano A: Methylenetetrahydrofolate reductase (MTHFR) polymorphism increases the risk of cervical intraepithelial neoplasia. Anticancer Res 20: 1751-1757, 2000.
12. Shen H, Xu Y, Zheng Y, Qian Y, Yu R, Qin Y, Wang X, Spitz MR and Wei Q: Polymorphisms of 5,10-methylenetetrahydrofolate reductase and risk of gastric cancer in a Chinese population: a case-control study. Int J Cancer 95: 332-336, 2001.
13. Song C, Xing D, Tan W, Wei Q and Lin D: Methylenetetrahydrofolate reductase polymorphisms increase risk of esophageal squamous cell carcinoma in a Chinese population. Cancer Res 61: 3272-3275, 2001.
14. Wiemels JL, Smith RN, Taylor GM, Eden OB, Alexander FE and Greaves MF: Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and risk of molecularly defined subtypes of childhood acute leukemia. Proc Natl Acad Sci USA 98: 4004-4009, 2001.
15. Gonzalez Ordonez AJ, Fernandez Carreira JM, Fernandez Alvarez CR, Martin L, Sanchez Garcia J, Medina Rodriguez JM, Alvarez MV and Coto E: Normal frequencies of the C677T genotypes on the methylenetetrahydrofolate reductase (MTHFR) gene among lymphoproliferative disorders but not in multiple myeloma. Leuk Lymphoma 39: 607-612, 2002.
16. Singal R, Ferdinand L, Das PM, Reis IM and Schlesselman JJ: Polymorphisms in the methylenetetrahydrofolate reductase gene and prostate cancer risk. Int J Oncol 25: 1465-1471, 2004.
17. Siemianowicz K, Gminski J, Garczorz W, Slabiak N, Goss M, Machalski M and Magiera-Molendowska H: Methylenetetrahydrofolate reductase gene C677T and A1298C polymorphisms in patients with small cell and non-small cell lung cancer. Oncol Rep 10: 1341-1344, 2003.
18. Gemmati D, Ongaro A, Scapoli GL, Della Porta M, Tognazzo S, Serino ML, Di Bona E, Rodeghiero F, Gilli G, Reverberi R, Caruso A, Pasello M, Pellati A and De Mattei M: Common gene polymorphisms in the metabolic folate and methylation pathway and the risk of acute lymphoblastic leukemia and non-Hodgkin's lymphoma in adults. Cancer Epidemiol Biomarkers Prev 13: 787-794, 2004.
19. Matsuo K, Hamajima N, Suzuki R, Ogura M, Kagami Y, Taji H, Yasue T, Mueller NE, Nakamura S, Seto M, Morishima Y and Tajima K: Methylenetetrahydrofolate reductase gene (MTHFR) polymorphisms and reduced risk of malignant lymphoma. Am J Hematol 77: 351-357, 2004.
20. Skibola CF, Forrest MS, Coppede F, Agana L, Hubbard A, Smith MT, Bracci PM and Holly EA: Polymorphisms and haplotypes in folate-metabolizing genes and risk of non-Hodgkin lymphoma. Blood 104: 2155-2162, 2004.
21. Gershoni-Baruch R, Dagan E, Israeli D, Kasinetz L, Kadouri E and Friedman E: Association of the C677T polymorphism in the MTHFR gene with breast and/or ovarian cancer risk in Jewish women. Eur J Cancer 36: 2313-2316, 2000.
22. Campbell IG, Baxter SW, Eccles DM and Choong DYH: Methylenetetrahydrofolate reductase polymorphism and susceptibility to breast cancer. Breast Cancer Res 4: R14, 2002.
23. Semenza JC, Delfinom RJ, Ziogas A and Anton-Culver H: Breast cancer risk and methylenetetrahydrofolate reductase polymorphism. Breast Cancer Res Treat 77: 217-223, 2003.
24. Ergul E, Sazci A, Utkan Z and Canturk NZ: Polymorphisms in the MTHFR gene are associated with breast cancer. Tumour Biol 24: 286-290, 2003.
25. Forsti S, Angelini F, Festa S, Sanyal S, Zhang Z, Grzybowska E, Pamula J, Pekala W, Zientek H, Hemminki K and Kumar R: Single nucleotide polymorphisms in breast cancer. Oncol Rep 11: 917-922, 2004.
26. Langsenlehner U, Krippl P, Renner W Yazdani-Biuki B, Wolf G, Wascher TC, Paulweber B, Weitzer W and Samonigg H: The common 677C>T gene polymorphism of methylenetetrahydrofolate reductase gene is not associated with breast cancer risk. Breast Cancer Res Treat 81: 169-172, 2003.
27. Lee SA, Kang D, Nishio H, Lee MJ, Kim DH, Han W, Yoo KY, Ahn $H, Choe KJ, Hirvonen A and Noh DY: Methylenetetrahydrofolate reductase polymorphism, diet, and breast cancer in Korean women. Exp Mol Med 36: 116-121, 2004.
28. Deligezer D, Akisik E and Dalay N: Genotyping of the MTHFR gene polymorphism, C677T in patients with leukemia by melting curve analysis. Mol Diagn 7: 181-185, 2003.
29. Nakamura S, Aoshima T, Ikeda M, Sekido Y, Shimokata K and Niwa T: Simultaneous detection of methylenetetrahydrofolate reductase gene polymorphisms, C677T and A1298C, by melting curve analysis with LightCycler. Anal Biochem 306: 40-43, 2002.
30. Antoniadi T, Hatzis T, Kroupis C, Economou-Petersen E and Petersen MB: Prevalence of factor V leiden, prothrombin G20210A, and MTHFR C677T mutations in a Greek population of blood donors. Am J Hematol 61: 265-267, 1999.
31. Goodman MT, Mc Duffie K, Hernandez B, Wilkens LR, Bertram CC, Killeen J, Le Marchand L, Selhub J, Murphy S and Donlon TA: Association of methylenetetrahydrofolate reductase polymorphism C677T and dietary folate with the risk of cervical dysplasia. Cancer Epidemiol Biomarkers Prev 10: 1275-1280, 2001.
32. Gerhard DS, Nguyen LT, Zhang ZY, Borecki IB, Coleman BI and Rader JS: A relationship between methylenetetrahydrofolate reductase variants and the development of invasive cervical cancer. Gynecol Oncol 90: 560-565, 2003.
33. Shrubsole MJ, Gao YT, Cai Q, Shu XO, Dai Q, Hebert JR, Jin F and Zheng W: MTHFR polymorphisms, dietary folate intake, and breast cancer risk: results from the Shanghai Breast Cancer Study. Cancer Epidemiol Biomarkers Prev 13: 190-196, 2004.